Theriva Biologics News

Theriva Biologics | S-3: Registration statement for specified transactions by certain issuers

May 3 05:02

Theriva Biologics | 8-K: Current report

May 3 00:03

Theriva Biologics | 8-K: Current report

Apr 23 19:04

Theriva Biologics | 8-K: Current report

Apr 23 04:42

Theriva Biologics | 8-K: Current report

Apr 16 20:05

Theriva Biologics | 10-K: Annual report

Mar 26 04:26

Theriva Biologics | 8-K: Current report

Mar 25 19:43

Theriva Biologics | 8-K: Current report

Feb 7 21:15

Theriva Biologics | 8-K: Current report

Jan 8 13:00

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A

Dec 16, 2023 05:07

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Wolf Jeffrey Alan

Dec 16, 2023 05:01

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Kraws Jeffrey J

Dec 16, 2023 05:00

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director MONAHAN JOHN J

Dec 16, 2023 05:00

Theriva Biologics: Q3 2023 Earnings Report

Nov 13, 2023 21:15

Theriva Biologics | 8-K: Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results

Nov 13, 2023 21:10

Theriva Biologics | 8-K: Current report

Oct 23, 2023 19:10

Theriva Biologics | 8-K: Current report

Oct 17, 2023 18:05

Theriva Biologics | 8-K: Current report

Oct 3, 2023 18:06

Theriva Biologics | DEFR14A: Definitive proxy statement in connection with contested solicitations

Aug 17, 2023 05:24

Theriva Biologics | ARS: Annual Report to Security Holders

Aug 15, 2023 21:53